{
    "clinical_study": {
        "@rank": "168209", 
        "acronym": "CRAPO", 
        "arm_group": [
            {
                "arm_group_label": "Ropivacaine alone group", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Ropivacaine/Clonidine group", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a study conducted in 60 patients, randomly assigned to one of two groups of 30: the\n      first will receive ropivacaine alone and the second will receive the association\n      ropivacaine/clonidine.\n\n      The aim of the study is to prove that the association of Clonidine with Ropivacaine is more\n      effective than ropivacaine alone for locoregional anaesthesia of the eye for retinal\n      surgery.\n\n      The principal interest of this association of drugs is that it procures faster and longer\n      anaesthesia of the eye with less ropivacaine (therefore fewer injections). This provides\n      greater comfort to the patient during and after the intervention."
        }, 
        "brief_title": "Clonidine - Ropivacaine in Peribulbar Anesthesia", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Indication for Surgery of the Posterior Segment Under Locoregional Anaesthesia", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients who have given written informed consent\n\n          -  any adult patient about to undergo their first operation involving the posterior\n             segment of the eye under peribulbar anaesthesia\n\n        Exclusion Criteria:\n\n          -  persons without National Health Insurance\n\n          -  pregnant or breast-feeding women, patients < 18, patients who cannot give their\n             consent, patient's refusal of Loco-Regional Anesthesia, patients who cannot remain in\n             dorsal decubitus dorsal for at least 1h\n\n          -  contra-indication for Loco-Regional Anesthesia\n\n          -  hypersensitivity to the study drugs (ropivacaine, clonidine), to the corresponding\n             excipients or hypersensitivity to local anaesthetics other than amide-type\n             ropivacaine.\n\n          -  disorders of periorbital or oculomotor sensitivity, patients with glaucoma, patients\n             with chronic pain and on morphines\n\n          -  uncontrolled arterial hypertension, clonidine per os at home, arterial hypotension\n             before the intervention (SAP < 90 mmHg)\n\n          -  Surgery for diabetic retinopathy, patients with unbalanced diabetes, eye with prior\n             posterior segment surgery\n\n          -  Contra-indications mentioned on the summary of product characteristics for clonidine\n             (known hypersensitivity to the active ingredients or one of its excipients, Heart\n             rate below 60bpm, severe Bradycardia due to sinoatrial node disease or second or\n             third degree atrioventricular block, Depression, Sultopride)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01963299", 
            "org_study_id": "GIRARD-BERTRAND 2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ropivacaine alone group", 
                "intervention_name": "5 ml Ropivacaine 10% + physiological saline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ropivacaine/Clonidine group", 
                "intervention_name": "5 ml Ropivacaine 10% + Clonidine 1 \u00b5g/kg", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Ropivacaine", 
                "Clonidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Dijon", 
                    "country": "France", 
                    "zip": "21"
                }, 
                "name": "CHU Dijon"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Randomised Double-blind Study to Compare Ropivacaine 10mg/mL Alone Versus Ropivacaine 10mg/mL Associated With Clonidine 1\u00b5g/kg for Peribulbar Anesthesia in Posterior Eye Surgery", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Dose of ropivacaine injected 10 mg/ml: necessary to obtain complete ocular akinesia", 
            "safety_issue": "No", 
            "time_frame": "up to 1 hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01963299"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Time to achieve akinesia", 
            "safety_issue": "No", 
            "time_frame": "up to 1 hour"
        }, 
        "source": "Centre Hospitalier Universitaire Dijon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Dijon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}